Puma Biotechnology Licensing Partner Specialised Therapeutics Receives Marketing Approval in Singapore for NERLYNX (neratinib) for Extended Adjuvant Treatment...
LOS ANGELES--(BUSINESS WIRE)--Dec 2, 2019--
LOS ANGELES--(BUSINESS WIRE)--Dec 2, 2019--